Skip to main content

Vestal Point Capital, LP

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1974915 NEW YORK, NY

Position in KALV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$37,240,500
+$6,717,000 QoQ
Shares Held
1,850,000
-2.1% QoQ
Ownership
3.47%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#11
of 182 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in KALV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $2,697,459,670 across 67 Biotechnology names. KALV ranks #24 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KALV

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $37,240,500 1,850,000
2025-12-31 $30,523,500 1,890,000
2025-09-30 $9,135,000 750,000
2025-06-30 $52,850,875 4,675,000
2025-03-31 $54,829,909 4,751,292
2024-12-31 $40,401,900 4,770,000
2024-09-30 $46,320,000 4,000,000
2024-06-30 $27,094,000 2,300,000
2024-03-31 $7,768,300 655,000